Stay updated on NSCLC Immunotherapy Clinical Trial
Sign up to get notified when there's something new on the NSCLC Immunotherapy Clinical Trial page.

Latest updates to the NSCLC Immunotherapy Clinical Trial page
- Check2 days agoChange DetectedThe page's revision was updated from v3.6.0 to v3.6.1, indicating a minor platform update. This change does not alter the study details or other user-visible content.SummaryDifference0.0%

- Check9 days agoNo Change Detected
- Check24 days agoChange DetectedThe page now displays Revision: v3.5.5, replacing the previous v3.5.4, indicating a minor update to the page’s metadata/versioning rather than altering the study content.SummaryDifference0.0%

- Check38 days agoChange DetectedThe page's revision tag was updated from v3.5.3 to v3.5.4, signaling a new documentation version. This update reflects a minor change to the page’s documentation rather than to the study details or layout.SummaryDifference0.0%

- Check53 days agoChange DetectedThe Taiwan location label in the locations list was updated from Taoyuan, Taiwan, 333 to Taoyuan City, Taiwan, 333. The update keeps the same address but uses the official city designation for that site.SummaryDifference0.0%

- Check60 days agoChange DetectedThe revision label on the page has been updated from v3.5.2 to v3.5.3, indicating a new page revision is now in effect. This appears to be a metadata or versioning update rather than a substantive change to the study details.SummaryDifference0.0%

- Check67 days agoChange DetectedUpdated the Chile location text by removing the “Región de Valparaíso” wording while keeping the same city/address line. Also reflects minor text formatting changes for the sponsor name and a software revision/version string.SummaryDifference0.2%

Stay in the know with updates to NSCLC Immunotherapy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the NSCLC Immunotherapy Clinical Trial page.